ARKK vs LMAT
ARK Innovation ETF (ARKK) versus LeMaitre Vascular Inc (LMAT) — a side-by-side from cached financials, not a winner call.
ARK Innovation ETF (ARKK) common stock listed on US.
LeMaitre Vascular Inc (LMAT) is a medical instruments & supplies company listed on US.
ARKK does not have a complete income-statement cache yet.
Latest reported LMAT revenue for 2026-06-30 was $136.9M. Net income was $32.7M. LMAT currently screens at market cap $2.16B and trailing P/E 34.8.
ARKK currently screens at market cap $0. LMAT currently screens at market cap $2.16B and trailing P/E 34.8.
Not investment advice. Open the ARKK and LMAT stock pages for the full models.
Not investment advice.